Articles from Equity Insider

The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech
Issued on behalf of Oncolytics Biotech Inc.
By Equity Insider · Via GlobeNewswire · January 8, 2026
THE CHOKE POINT: 5 Assets That Control the Bottleneck
Issued on behalf of GoldHaven Resources Corp.
By Equity Insider · Via GlobeNewswire · January 7, 2026
The $35B Secret: Why 'Decision Speed' is the New Gold Rush in Defense
Issued on behalf of VisionWave Holdings, Inc.
By Equity Insider · Via GlobeNewswire · January 7, 2026
Strategic Minerals Surge: Defense Spending Fuels Critical Metals Race
Issued on behalf of GoldHaven Resource Corp.
By Equity Insider · Via GlobeNewswire · January 6, 2026
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge
Issued on behalf of GT Biopharma, Inc.
By Equity Insider · Via GlobeNewswire · December 24, 2025
The Builder’s Market: 5 Gold Stocks Transitioning to Cash Flow
Issued on behalf of Lake Victoria Gold Ltd.
By Equity Insider · Via GlobeNewswire · December 31, 2025
Record Margins Drive Drilling Boom as Gold Miners Expand Resources
Issued on behalf of Lake Victoria Gold Ltd.
By Equity Insider · Via GlobeNewswire · December 11, 2025
The Great Gold Rotation: Smart Money Chases Strategic Assets as Gold Holds $4,300
Issued on behalf of GoldHaven Resource Corp.
By Equity Insider · Via GlobeNewswire · December 17, 2025
THE REALITY CHECK: 5 Assets Delivering Proof in a Speculative Market
Issued on behalf of Quantum Security Encryption Corp.
By Equity Insider · Via GlobeNewswire · December 11, 2025
Federal Contracts Now Demand Quantum Resilience as Data Harvest Accelerates
Issued on behalf of QSE - Quantum Secure Encryption Corp.
By Equity Insider · Via GlobeNewswire · December 16, 2025
Drilling Programs Define New Zones as Gold Still Targets $5,000
Issued on behalf of Lake Victoria Gold Ltd.
By Equity Insider · Via GlobeNewswire · November 25, 2025
Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards
Issued on behalf of Oncolytics Biotech Inc.
By Equity Insider · Via GlobeNewswire · December 16, 2025
Grade is King: Bonanza Discoveries Re-Rate The Gold Exploration Sector
Issued on behalf of Lake Victoria Gold Ltd.
By Equity Insider · Via GlobeNewswire · December 15, 2025
GI Cancer Immunotherapy Breakthroughs Signal New Treatment Era
Issued on behalf of Oncolytics Biotech Inc.
By Equity Insider · Via GlobeNewswire · December 12, 2025
Healthcare AI Exits Pilot Phase, Enters Production Deployment
Issued on behalf of VentriPoint Diagnostics Ltd.
By Equity Insider · Via GlobeNewswire · December 12, 2025
AI Attacks Surge 156% as Enterprises Rush to Lock Down Quantum-Vulnerable Systems
Issued on behalf of QSE - Quantum Secure Encryption Corp.
By Equity Insider · Via GlobeNewswire · December 9, 2025